Summary: The Centers for Medicare & Medicaid Services modified its Percutaneous Transluminal Angioplasty (PTA) coverage policy, effective May 15, 2026. Here's what billing teams need to do.
CMS updated its PTA coverage policy — one of the more financially significant vascular procedure policies in Medicare billing. Percutaneous transluminal angioplasty covers a range of arterial and venous interventions, and CMS policy changes here ripple across cardiology, interventional radiology, and vascular surgery billing. The policy document does not list specific codes in the data available at publication. Review the full policy at the CMS source before May 15, 2026 to confirm how this modification affects your charge capture.
| Field | Detail |
|---|---|
| Payer | Centers for Medicare & Medicaid Services (CMS) |
| Policy | Percutaneous Transluminal Angioplasty (PTA) |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | 2026-05-15 |
| Impact Level | High |
| Specialties Affected | Interventional Radiology, Cardiology, Vascular Surgery, Interventional Cardiology |
| Key Action | Review the full updated policy before May 15, 2026 and audit your PTA claims against the revised medical necessity criteria |
CMS Percutaneous Transluminal Angioplasty Coverage Criteria and Medical Necessity Requirements 2026
The CMS percutaneous transluminal angioplasty coverage policy governs whether Medicare reimburses for balloon-based arterial and venous dilation procedures across a wide range of vascular beds — coronary, peripheral, renal, carotid, and more. This is not a niche policy. PTA touches virtually every interventional specialist who bills Medicare.
The policy was modified with an effective date of May 15, 2026. Because the policy data available at publication does not include a full summary of the specific criteria changes, the precise language of what shifted — coverage thresholds, medical necessity definitions, prior authorization triggers, or indication-level status changes — requires you to pull the source document directly at the CMS policy link.
That said, here is what you need to understand about PTA coverage policy as it stands, and what typically drives modifications of this type.
What Medical Necessity Means for PTA Under Medicare
Medical necessity for PTA procedures under Medicare historically requires documented hemodynamically significant stenosis, failure of or contraindication to conservative management, and an appropriate clinical indication tied to the specific vascular territory being treated. The standard is not just that stenosis exists — CMS requires evidence that the lesion is clinically significant and that the procedure is the appropriate intervention for that patient.
When CMS modifies a PTA policy, it typically tightens or clarifies one of three things: the degree of stenosis required, the clinical documentation requirements, or the range of covered indications. Any of those shifts can produce claim denials if your documentation doesn't align with the updated language.
Medical necessity documentation is the most common reason PTA claims get flagged during post-payment review. If this modification added or changed a criterion, your operative notes, imaging reports, and pre-procedure workup documentation all need to reflect the updated standard before claims go out after May 15, 2026.
Prior Authorization and PTA Billing
Prior authorization requirements for PTA vary by setting, payer, and vascular territory. Under Medicare fee-for-service, prior authorization is not universally required for all PTA procedures — but Medicare Advantage plans administered through CMS-contracted insurers frequently do require it. If your patient population includes Medicare Advantage enrollees, check each plan's coverage policy separately.
The real issue with PTA and prior authorization is that the clinical criteria in the prior auth request need to match the updated CMS coverage policy language. If CMS tightened the medical necessity definition and your prior auth template still uses the old criteria, you're approving procedures under outdated standards. That creates downstream claim denial risk even when the prior auth itself was granted.
CMS Percutaneous Transluminal Angioplasty Exclusions and Non-Covered Indications
PTA has a well-established list of historically non-covered or experimental applications under Medicare. While the specific exclusions in this modified policy version are not detailed in the data available at publication, the following categories have historically been subject to non-coverage determinations or medical necessity scrutiny under CMS policy.
Procedures historically scrutinized or excluded:
| # | Excluded Procedure |
|---|---|
| 1 | PTA for indications where surgical revascularization is the established standard and PTA is unproven in that vascular territory |
| 2 | Carotid PTA without stenting in standard-surgical-risk patients, where carotid endarterectomy remains the covered standard |
| 3 | PTA for non-occlusive disease without documented hemodynamic significance |
| 4 | Repeated PTA for restenosis beyond established re-intervention thresholds |
| 5 | PTA in combination with investigational devices or adjunct therapies under active clinical trial protocols — these often fall under coverage with evidence development (CED) requirements rather than standard coverage |
If this policy modification changed the status of any indication — moving it from covered to non-covered, or from experimental to covered — your billing team needs that information before May 15, 2026. Pull the full policy document and compare it against your current charge description master entries.
Coverage Indications at a Glance
The policy data provided at publication does not include indication-level coverage status detail. The table below reflects the general CMS framework for PTA coverage based on established Medicare policy patterns. Confirm each row against the actual modified policy before the effective date of May 15, 2026.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Peripheral arterial disease with hemodynamically significant stenosis | Generally Covered | See full policy | Medical necessity documentation required |
| Coronary artery disease — PTA (balloon angioplasty) | Generally Covered | See full policy | Separate coronary coverage criteria apply |
| Renal artery stenosis — atherosclerotic | Covered with criteria | See full policy | Strict medical necessity criteria; prior auth common under MA plans |
| Renal artery stenosis — fibromuscular dysplasia | Covered with criteria | See full policy | Clinical documentation of FMD required |
| Carotid artery stenosis | Coverage varies | See full policy | CED requirements may apply; high-risk surgical criteria |
| Subclavian/brachiocephalic stenosis | Generally Covered | See full policy | Symptomatic criteria typically required |
| Venous stenosis/occlusion | Coverage varies by indication | See full policy | Dialysis access interventions have separate criteria |
| PTA for investigational indications | Not Covered / Experimental | N/A | CED or clinical trial enrollment may be required |
This table is a starting framework — not a substitute for the actual updated policy language. Verify every row against the source document.
CMS Percutaneous Transluminal Angioplasty Billing Guidelines and Action Items 2026
This is where most billing teams drop the ball: they hear about a policy modification, put it on a to-do list, and then the effective date passes before anyone actually audits the workflow. Don't do that here. PTA billing is high-dollar and high-scrutiny. One criterion change can flip a covered claim into a denial overnight.
| # | Action Item |
|---|---|
| 1 | Pull the full modified policy now. Go to the CMS source at https://app.payerpolicy.org/p/cms/201-v11 and download the current version. Compare it line-by-line against the previous version. The specific criterion changes are what drive your action list — you can't build that list without reading the document. |
| 2 | Update your medical necessity documentation templates before May 15, 2026. If the modified policy added, changed, or removed a criterion, your pre-procedure note templates, H&P formats, and operative note structures need to reflect the new language. This includes both the clinical documentation your physicians generate and the supporting documentation your billing team pulls for claims. |
| 3 | Audit open prior authorizations for PTA procedures scheduled after May 15, 2026. Any prior auth approved under the old criteria may not align with the new coverage policy language. Contact your Medicare Advantage payers to confirm whether existing authorizations remain valid after the effective date. Don't assume they carry over automatically. |
| 4 | Review your charge description master entries for PTA codes. Confirm that the CPT codes your team is billing for PTA procedures match the updated policy's covered indications. If the policy added new exclusions or changed the covered-indication scope, some codes may need updated charge capture flags or modifier requirements. Because this policy does not list specific codes in the available data, work directly from the full policy document to identify the affected code set. |
| 5 | Check your MAC's local coverage determinations. CMS national policy sets the floor — your Medicare Administrative Contractor may have a local coverage determination (LCD) that adds stricter criteria on top of the national policy. Contractors like Novitas, CGS, or WPS may update their LCDs in response to this CMS modification. Pull your MAC's current PTA LCD and compare it against the updated national policy before May 15, 2026. |
| 6 | Brief your interventional physicians on the changes. The billing team can't fix a claim denial caused by insufficient clinical documentation after the fact. Get the updated criteria in front of your interventionalists, cardiologists, and vascular surgeons before the effective date. A two-page summary of what changed is more useful than a general policy update email. |
| 7 | Set a claim audit trigger for PTA claims submitted after May 15, 2026. Pull the first 30 days of post-effective-date PTA claims and review them for alignment with the new criteria before they hit 90 days outstanding. Catching documentation gaps early keeps denials manageable. If you're seeing a pattern, you can fix the template before it compounds. |
If you're unsure how this modification applies to your specific procedure mix or payer contracts, talk to your compliance officer or billing consultant before May 15, 2026. PTA reimbursement rates are high enough that systematic denials have real revenue impact.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Percutaneous Transluminal Angioplasty Under This Policy
The policy data provided at publication does not include specific CPT, HCPCS, or ICD-10 codes. Do not rely on externally sourced code lists as a substitute for the actual policy document.
PTA billing spans a wide range of CPT codes depending on the vascular territory, approach, and whether additional interventions (stenting, atherectomy, thrombolysis) are performed alongside the angioplasty. The correct code set for your procedures must be confirmed against the full modified policy document.
What to do instead of using a generic code list:
Pull the source policy and identify every CPT and HCPCS code referenced in the coverage criteria, indications, and non-covered sections. Build your code-specific action list from the actual policy language. If your billing team needs help mapping the policy language to your current charge capture, your coding consultant or a certified interventional radiology coder is the right resource.
Once you have the actual code list from the policy, use it to:
- Cross-reference your CDM entries
- Update your claim edits in your billing system
- Confirm that your prior auth requests reference the correct procedure codes under the updated coverage policy
Billing guidelines that aren't anchored to the actual policy codes aren't billing guidelines — they're guesses. Get the codes from the source.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.